27 related articles for article (PubMed ID: 37178666)
1. Discovery of C-3 isoxazole substituted thiochromone S,S-dioxide derivatives as potent and selective inhibitors for monoamine oxidase B (MAO-B).
Mi P; Tan Y; Ye S; Lang JJ; Lv Y; Jiang J; Chen L; Luo J; Lin Y; Yuan Z; Zheng X; Lin YW
Eur J Med Chem; 2024 Jan; 263():115956. PubMed ID: 37992521
[TBL] [Abstract][Full Text] [Related]
2. Novel 6-hydroxybenzothiazol-2-carboxamides as potent and selective monoamine oxidase B inhibitors endowed with neuroprotective activity.
Al-Saad OM; Gabr M; Darwish SS; Rullo M; Pisani L; Miniero DV; Liuzzi GM; Kany AM; Hirsch AKH; Abadi AH; Engel M; Catto M; Abdel-Halim M
Eur J Med Chem; 2024 Apr; 269():116266. PubMed ID: 38490063
[TBL] [Abstract][Full Text] [Related]
3. Isatin-tethered halogen-containing acylhydrazone derivatives as monoamine oxidase inhibitor with neuroprotective effect.
Kumar S; Oh JM; Prabhakaran P; Awasti A; Kim H; Mathew B
Sci Rep; 2024 Jan; 14(1):1264. PubMed ID: 38218887
[TBL] [Abstract][Full Text] [Related]
4. Potent, selective and reversible hMAO-B inhibition by benzalphthalides: Synthesis, enzymatic and cellular evaluations and virtual docking and predictive studies.
Olmo ED; Barboza B; Delgado-Esteban M; Escala N; Jiménez-Blasco D; Lopez-Pérez JL; Cillero de la Fuente L; Quezada E; Munín J; Viña D; Bolaños JP; Feliciano AS
Bioorg Chem; 2024 May; 146():107255. PubMed ID: 38457955
[TBL] [Abstract][Full Text] [Related]
5. In Vitro Human Monoamine Oxidase Inhibition and Human Dopamine D
Paudel P; Choi JS; Prajapati R; Seong SH; Park SE; Kang WC; Ryu JH; Jung HA
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958841
[TBL] [Abstract][Full Text] [Related]
6. Non-cytotoxic 3-Acetylcoumarin as an Attractive Target for Human Monoamine Oxidase (HMAO) Enzymes.
Aghimien MO; Kolawole Q; Igbinoba PO; Musa MA; Latinwo L
Anticancer Res; 2024 Jun; 44(6):2335-2341. PubMed ID: 38821578
[TBL] [Abstract][Full Text] [Related]
7. Exploration of oxadiazole clubbed benzhydrylpiperazine pharmacophoric features as structural feature for antidepressant activity: In vitro, in vivo and in silico analysis.
Kumar Nandi N; Das S; Choudhary D; Saini S; Bhatia R; Chawla P; Kaur R; Kalra S; Rawat R; Eyupoglu V; Kumar B
Bioorg Chem; 2024 Mar; 144():107148. PubMed ID: 38306828
[TBL] [Abstract][Full Text] [Related]
8. MAO inhibitory activity of bromo-2-phenylbenzofurans: synthesis,
Delogu GL; Pintus F; Mayán L; Matos MJ; Vilar S; Munín J; Fontenla JA; Hripcsak G; Borges F; Viña D
Medchemcomm; 2017 Sep; 8(9):1788-1796. PubMed ID: 30108888
[TBL] [Abstract][Full Text] [Related]
9. Structure-based design of multitargeting ChEs-MAO B inhibitors based on phenyl ring bioisosteres: AChE/BChE selectivity switch and drug-like characterization.
La Spada G; Miniero DV; Rullo M; Cipolloni M; Delre P; Colliva C; Colella M; Leonetti F; Liuzzi GM; Mangiatordi GF; Giacchè N; Pisani L
Eur J Med Chem; 2024 May; 274():116511. PubMed ID: 38820854
[TBL] [Abstract][Full Text] [Related]
10. High-throughput discovery of highly selective reversible hMAO-B inhibitors based on at-line nanofractionation.
Fan Y; Wang J; Jian J; Wen Y; Li J; Tian H; Crommen J; Bi W; Zhang T; Jiang Z
Acta Pharm Sin B; 2024 Apr; 14(4):1772-1786. PubMed ID: 38572096
[TBL] [Abstract][Full Text] [Related]
11. A Tiny Pocket Packs a Punch: Leveraging Pyridones for the Discovery of CNS-Penetrant Aza-indazole IRAK4 Inhibitors.
Bolduc PN; Pfaffenbach M; Evans R; Xin Z; Henry KL; Gao F; Fang T; Silbereis J; Vera Rebollar J; Li P; Chodaparambil JV; Metrick C; Peterson EA
ACS Med Chem Lett; 2024 May; 15(5):714-721. PubMed ID: 38746903
[TBL] [Abstract][Full Text] [Related]
12. Discovery of 3,4-dichloro-N-(1H-indol-5-yl)benzamide: A highly potent, selective, and competitive hMAO-B inhibitor with high BBB permeability profile and neuroprotective action.
Elkamhawy A; Kim HJ; Elsherbeny MH; Paik S; Park JH; Gotina L; Abdellattif MH; Gouda NA; Cho J; Lee K; Nim Pae A; Park KD; Roh EJ
Bioorg Chem; 2021 Nov; 116():105352. PubMed ID: 34562673
[TBL] [Abstract][Full Text] [Related]
13. Pyrimido[1,2-b]indazole derivatives: Selective inhibitors of human monoamine oxidase B with neuroprotective activity.
Jismy B; El Qami A; Pišlar A; Frlan R; Kos J; Gobec S; Knez D; Abarbri M
Eur J Med Chem; 2021 Jan; 209():112911. PubMed ID: 33071056
[TBL] [Abstract][Full Text] [Related]
14. Indazole- and indole-5-carboxamides: selective and reversible monoamine oxidase B inhibitors with subnanomolar potency.
Tzvetkov NT; Hinz S; Küppers P; Gastreich M; Müller CE
J Med Chem; 2014 Aug; 57(15):6679-703. PubMed ID: 24955776
[TBL] [Abstract][Full Text] [Related]
15. Synthetic approaches to unsymmetrical 2,5-disubstituted 1,3,4-oxadiazoles and their MAO-B inhibitory activity. A review.
Karabelyov V; Kondeva-Burdina M; Angelova VT
Bioorg Med Chem; 2021 Jan; 29():115888. PubMed ID: 33360082
[TBL] [Abstract][Full Text] [Related]
16. Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors.
Rullo M; La Spada G; Miniero DV; Gottinger A; Catto M; Delre P; Mastromarino M; Latronico T; Marchese S; Mangiatordi GF; Binda C; Linusson A; Liuzzi GM; Pisani L
Eur J Med Chem; 2023 Jul; 255():115352. PubMed ID: 37178666
[TBL] [Abstract][Full Text] [Related]
17. Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors.
Tzvetkov NT; Stammler HG; Neumann B; Hristova S; Antonov L; Gastreich M
Eur J Med Chem; 2017 Feb; 127():470-492. PubMed ID: 28107736
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
